| Financial Year |
March 31 2023 |
| Monetary Funds |
694,151,449.18 |
| Held-for-trading Financial Assets |
34,781,638.41 |
| Notes Receivable |
138,710,654.79 |
| Accounts Receivable |
980,937,256.18 |
| Advances to Suppliers |
158,640,094.77 |
| Other Receivables |
128,179,060.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,388,596,098.33 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
87,641,860.38 |
| Total Current Assets |
6,477,583,482.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
681,326.42 |
| Long-term Equity Investment |
7,115,116.27 |
| Investment Properties |
20,109,419.76 |
| Fixed Assetes |
1,681,729,467.47 |
| Under-construction Projects |
323,350,356.53 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,068,492,853.50 |
| R&D expenses |
82,999,666.06 |
| Goodwill |
872,811,223.23 |
| Long-Term Deferred and Prepaid Expenses |
12,624,674.22 |
| Deferred Income Tax Assets |
104,747,794.66 |
| Other Non-Current Assets |
88,635,411.57 |
| Sub-Total of Non-Current Assets |
4,339,141,973.47 |
| Total Assets |
10,816,725,455.99 |
| Short-Term Loans |
398,937,170.85 |
| Trading Financial liabilities |
-- |
| Notes Payable |
362,187,341.31 |
| Accounts Payable |
1,389,388,690.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
189,829,438.80 |
| Taxes Payable |
80,482,965.29 |
| Interest Payable |
-- |
| Dividend Payable |
146,341.78 |
| Other payables |
126,092,953.97 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,717,314.67 |
| Other Current Liabilities |
347,331,551.58 |
| Sub-Total of Current Liabilities |
5,562,888,934.97 |
| Long-term Loans |
181,275,330.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
122,582,987.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
38,476,764.94 |
| Deferred Income Tax Liabilities |
191,516,534.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
798,087,986.34 |
| Total Liabilities |
6,360,976,921.31 |
| Paid-In Capital(Or Share Stock) |
575,052,984.00 |
| Capital Surplus |
1,699,783,782.66 |
| Surplus Reserve |
175,457,784.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,943,021,048.02 |
| Minority Stockholder's Interest |
89,971,572.01 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,365,776,962.67 |
| Owner's Equity（Stockholder's Equity） |
4,455,748,534.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,816,725,455.99 |
